Loading…
Johnson & Johnson MedTech completed the acquisition of V-Wave, gaining the Ventura Interatrial Shunt System for heart failure patients with reduced ejection fraction.
Johnson & Johnson has entered into a definitive agreement to acquire V-Wave Ltd., a developer of heart failure treatment devices, for an upfront payment of $600 million plus potential milestone payments up to approximately $1.1 billion. V-Wave's Ventura Interatrial Shunt is designed to treat heart failure.